Harnessing the Power of Polyphenols: A New Frontier in Disease Prevention and Therapy
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(6), P. 692 - 692
Published: May 27, 2024
There
are
a
wide
variety
of
phytochemicals
collectively
known
as
polyphenols.
Their
structural
diversity
results
in
broad
range
characteristics
and
biological
effects.
Polyphenols
can
be
found
foods
drinks,
including
fruits,
cereals,
tea,
coffee.
Studies
both
vitro
vivo,
well
clinical
trials,
have
shown
that
they
possess
potent
antioxidant
activities,
numerous
therapeutic
effects,
health
advantages.
Dietary
polyphenols
demonstrated
the
potential
to
prevent
many
problems,
obesity,
atherosclerosis,
high
blood
sugar,
diabetes,
hypertension,
cancer,
neurological
diseases.
In
this
paper,
protective
effects
mechanisms
behind
them
investigated
detail,
citing
most
recent
available
literature.
This
review
aims
provide
comprehensive
overview
current
knowledge
on
role
preventing
managing
chronic
The
cited
publications
derived
from
vitro,
human-based
studies
trials.
A
more
complete
understanding
these
naturally
occurring
metabolites
will
pave
way
for
development
novel
polyphenol-rich
diet
drug
programs.
This,
turn,
provides
further
evidence
their
benefits.
Language: Английский
Microbiome’s role in musculoskeletal health through the gut-bone axis insights
Gut Microbes,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Oct. 10, 2024
The
interplay
between
the
human
microbiome
and
musculoskeletal
system
represents
a
burgeoning
field
of
research
with
profound
implications
for
understanding
treating
disorders.
This
review
articulates
pivotal
role
in
modulating
bone
health,
highlighting
gut-bone
axis
as
critical
nexus
potential
therapeutic
intervention.
Through
meticulous
analysis
recent
clinical
research,
we
underscore
microbiome's
influence
on
osteoporosis,
sarcopenia,
osteoarthritis,
rheumatoid
arthritis,
delineating
both
direct
indirect
mechanisms
by
which
microbiota
could
impact
integrity
function.
Our
investigation
reveals
novel
insights
into
microbiota's
contribution
to
density
regulation,
hormone
production,
immune
modulation,
nutrient
absorption,
laying
groundwork
innovative
microbiome-based
strategies
disease
management.
Significantly,
identify
challenges
hindering
translation
practice,
including
limitations
current
microbial
sequencing
techniques
need
standardized
methodologies
studies.
Furthermore,
highlight
promising
directions
future
particularly
realm
personalized
medicine,
where
variability
offers
unique
opportunities
tailored
treatment
approaches.
sets
new
agenda
leveraging
gut
diagnosis,
prevention,
conditions,
marking
step
toward
integrating
science
care.
Language: Английский
Diabetic Rats Induced Using a High-Fat Diet and Low-Dose Streptozotocin Treatment Exhibit Gut Microbiota Dysbiosis and Osteoporotic Bone Pathologies
Kuo‐Chin Huang,
No information about this author
Po‐Yao Chuang,
No information about this author
Tien‐Yu Yang
No information about this author
et al.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(8), P. 1220 - 1220
Published: April 19, 2024
Type
2
diabetes
mellitus
(T2DM)
presents
a
challenge
for
individuals
today,
affecting
their
health
and
life
quality.
Besides
its
known
complications,
T2DM
has
been
found
to
contribute
bone/mineral
abnormalities,
thereby
increasing
the
vulnerability
bone
fragility/fractures.
However,
there
is
still
need
appropriate
diagnostic
approaches
targeted
medications
address
T2DM-associated
diseases.
This
study
aims
investigate
relationship
between
changes
in
gut
microbiota,
T2DM,
osteoporosis.
To
explore
this,
rat
model
was
induced
by
combining
high-fat
diet
low-dose
streptozotocin
treatment.
Our
findings
reveal
that
rats
have
lower
mass
reduced
levels
of
turnover
markers
compared
control
rats.
We
also
observe
significant
alterations
microbiota
rats,
characterized
higher
relative
abundance
Firmicutes
(F)
Proteobacteria
(P),
but
Bacteroidetes
(B)
at
phylum
level.
Further
analysis
indicates
correlation
F/B
ratio
levels,
as
well
B/P
HbA1c
levels.
Additionally,
genus
level,
we
an
inverse
Language: Английский
Functional foods for bone and joint health: building a solid foundation
Elsevier eBooks,
Journal Year:
2025,
Volume and Issue:
unknown, P. 233 - 256
Published: Jan. 1, 2025
Language: Английский
The Interplay of Aging and PANoptosis in Osteoarthritis Pathogenesis: Implications for Novel Therapeutic Strategies
Shaoshan Liu,
No information about this author
Guifeng Zhang,
No information about this author
Nan Li
No information about this author
et al.
Journal of Inflammation Research,
Journal Year:
2025,
Volume and Issue:
Volume 18, P. 1951 - 1967
Published: Feb. 1, 2025
Abstract:
Osteoarthritis
(OA)
is
a
common
degenerative
joint
disease
characterized
by
the
progressive
degradation
of
articular
cartilage,
synovial
inflammation,
and
subchondral
bone
remodeling.
This
review
explores
interplay
between
aging,
PANoptosis,
inflammation
in
OA
progression.
Age-related
cellular
immune
dysfunctions,
including
senescence,
senescence-associated
secretory
phenotypes
(SASPs),
immunosenescence,
significantly
contribute
to
degeneration.
In
OA,
dysregulated
apoptosis,
necroptosis,
pyroptosis,
particularly
chondrocytes,
exacerbate
cartilage
damage.
Apoptosis,
mediated
JNK
pathway,
reduces
chondrocyte
density,
while
necroptosis
involving
RIPK-1/RIPK-3
NLRP3
inflammasome,
respectively,
amplify
destruction.
Inflammatory
cytokines
damage-associated
molecular
patterns
(DAMPs)
further
enhance
these
PANoptotic
pathways.
Current
therapeutic
strategies
primarily
focus
on
anti-inflammatory
agents
such
as
non-steroidal
drugs
(NSAIDs)
corticosteroids,
with
growing
interest
anti-senescence
targeting
senescence
SASP.
Additionally,
exploring
PANoptosis
mechanisms
offers
potential
for
innovative
treatments.
Keywords:
osteoarthritis,
Language: Английский
Nutraceutical Additives Modulate Microbiota and Gut Health in Post-Weaned Piglets
Veterinary Sciences,
Journal Year:
2024,
Volume and Issue:
11(8), P. 332 - 332
Published: July 25, 2024
Due
to
the
challenge
of
weaning
pigs
and
need
reduce
use
antimicrobials
in
animal
feed,
there
is
a
growing
look
for
nutraceutical
alternatives
adverse
effects
post-weaning
period.
We
evaluate
effect
different
feed
additives
on
microbial
communities,
gut
health
biomarkers,
productivity
during
The
study
involved
240
piglets
weaned
21st
day
age
randomized
six
diets:
D1-BD
commercial
standard
D2-AGP:
D1
+
150
ppm
zinc
bacitracin,
D3-MD:
550
maltodextrin,
D4-FOS:
300
fructo-oligosaccharides,
D5-EO:
70
Language: Английский
The Effect of Lacticaseibacillus paracasei LPC100 and Lactiplantibacillus plantarum LP140 on Bone Mineral Density in Postmenopausal Women: A Multicenter, Randomized, Placebo-Controlled Study
Joanna Głogowska-Szeląg,
No information about this author
Ilona Palka-Kisielowska,
No information about this author
W. Porawska
No information about this author
et al.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(19), P. 5977 - 5977
Published: Oct. 8, 2024
modulation
of
gut
microbiota
by
probiotics
has
been
proposed
as
a
target
for
intervention
to
reduce
bone
mineral
density
(BMD)
loss
in
the
postmenopausal
period.
This
study
aims
evaluate
effect
Language: Английский
Bioactive Compounds and Their Chondroprotective Effects for Osteoarthritis Amelioration: A Focus on Nanotherapeutic Strategies, Epigenetic Modifications, and Gut Microbiota
Kota Sri Naga Hridayanka,
No information about this author
Asim K. Duttaroy,
No information about this author
Sanjay Basak
No information about this author
et al.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(21), P. 3587 - 3587
Published: Oct. 22, 2024
In
degenerative
joint
disease
like
osteoarthritis
(OA),
bioactive
compounds
resveratrol,
epigallocatechin
gallate,
curcumin,
and
other
polyphenols
often
target
various
signalling
pathways,
including
NFκB,
TGFβ,
Wnt/β-catenin
by
executing
epigenetic-modifying
activities.
Epigenetic
modulation
can
genes
of
pathophysiology
via
histone
modification,
promoter
DNA
methylation,
non-coding
RNA
expression,
some
which
are
directly
involved
in
OA
but
have
been
less
explored.
patients
seek
options
that
improve
the
quality
their
life
addition
to
existing
treatment
with
nonsteroidal
anti-inflammatory
drugs
(NSAIDs).
Although
natural
exhibit
therapeutic
potential
against
OA,
several
disadvantages
loom,
insolubility
poor
bioavailability.
Nanoformulated
promise
a
better
way
alleviate
since
they
also
control
systemic
events,
metabolic,
immunological,
inflammatory
responses,
modulating
host
gut
microbiota
regulate
pathogenesis.
Recent
data
suggest
dysbiosis
OA.
However,
limited
evidence
is
available
on
role
as
epigenetic
modulators
ameliorating
Moreover,
it
not
known
whether
effects
polyphenolic
microbial
response
mediated
modulatory
activities
This
narrative
review
highlights
nanotherapeutic
strategies
utilizing
compounds,
reporting
chondrocyte
growth,
metabolism,
modifications
amelioration.
Language: Английский
Mapping knowledge landscapes and research frontiers of gastrointestinal microbiota and bone metabolism: a text-mining study
Haiyang Wu,
No information about this author
Zaijie Sun,
No information about this author
Qiang Guo
No information about this author
et al.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2024,
Volume and Issue:
14
Published: July 10, 2024
Extensive
research
efforts
have
been
dedicated
to
elucidating
the
intricate
pathways
by
which
gastrointestinal
microbiota
and
their
metabolites
exert
influence
on
processes
of
bone
formation.
Nonetheless,
a
notable
gap
exists
in
literature
concerning
bibliometric
analysis
trends
at
nexus
metabolism.
Language: Английский